• EPH197 Using High Quality Open Data to Find Long Term Results in an Continuously Enrolled Population, an Example in BPH

    Jun 1, 2023, 00:00

  • HPR138 The Squeezed Middle - Sociodemographic Disparities in Prostate Cancer Presentation in Ireland - Results from the Irish Prostate Cancer Outcomes Research (IPCOR) Study

    Jun 1, 2023, 00:00

  • RWD22 A Novel Patient-Centered Real-World Evidence Study Designed to Better Understand Chronic Inflammatory Demyelinating Polyneuropathy Using Longitudinal Data in the United States

    Jun 1, 2023, 00:00

  • PCR164 Adherence to Botulinumtoxin Treatment: A 2-Year Retrospective Claims Database Analysis

    Jun 1, 2023, 00:00

  • MSR92 Racial and Smoking Status Disparities in Mediation Effects on Liraglutide-Associated Cardiovascular Outcomes: A Dynamic Path Analysis Using Leader Trial Data

    Jun 1, 2023, 00:00

  • HPR34 Impact of the Inflation Reduction Act on Pricing, Reimbursement, and Market Access in the US

    Jun 1, 2023, 00:00

  • RWD69 5-Year Graft Failure Outcomes Utilizing Kidneys with Higher Kidney Donor Profile Index Scores across Different Age Groups and Sex over a 10-Year Period

    Jun 1, 2023, 00:00

  • CO220 Real-World Effectiveness and Safety in a Phase 4 Study of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis

    Jun 1, 2023, 00:00

  • CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparison

    Jun 1, 2023, 00:00

  • CO96 Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction between Asian and White Patients: A Meta-Analysis of Randomized Outcomes Trials

    Jun 1, 2023, 00:00

  • EPH47 Active Surveillance for Safety Monitoring of COVID-19 Vaccines in Saudi Arabia

    Jun 1, 2023, 00:00

  • PCR233 Concept Elicitation Study to Characterize the Patient-Reported Experience of Gonorrhea Infection and Mapping of Concepts to Patient-Reported Outcome Measures

    Jun 1, 2023, 00:00

  • CO123 Health-Related Quality of Life (HRQOL) Among Mucopolysaccharidoses (MPS) Patients Receiving Enzyme Replacement Therapy (ERT): A Systematic Literature Review

    Jun 1, 2023, 00:00

  • HPR29 Health Equity Frameworks – Healthcare System Actions and Priorities

    Jun 1, 2023, 00:00

  • EE370 Estimating the Direct Economic Burden of Osteoporotic Fractures in a Multinational Study: A Real-World Data Perspective

    Jun 1, 2023, 00:00

  • EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • Perceived Importance of the Benefits and Harms of Colorectal Cancer Screening: A Best-Worst Scaling Study

    Jun 1, 2023, 00:00

  • CO187 The Framing of Time-Dependent Machine Learning Models Improves Risk Estimation Among Young Individuals with Acute Coronary Syndromes

    Jun 1, 2023, 00:00

  • SA63 Identification of Patients Diagnosed with Rare and Emerging Diseases Utilizing the Trinetx Network: A Case Study of African and American Trypanosomiasis

    Jun 1, 2023, 00:00

  • EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada

    Jun 1, 2023, 00:00

  • OP12 Reconciling Standardisation Processes and Improvisation Practices in Health Care: How to Deal with Structural, Clinical and Performative Unpredictability

    Jun 1, 2023, 00:00

  • Table of Contents

    Jun 1, 2023, 00:00

  • PCR237 Evaluating the Psychometric Properties of a Questionnaire Designed to Assess Headache Characteristics and Management Among United States Student Pharmacists

    Jun 1, 2023, 00:00

  • MSR77 Making a Case for Case Reports: A Scoping Review of the Use of and Challenges with Case Report Data in Quantitative Synthesis

    Jun 1, 2023, 00:00

  • EE257 Cost Effectiveness Analysis of Qulipta in Episodic Migraine Prophylaxis

    Jun 1, 2023, 00:00

  • CO72 Risk of Richter Transformation in Relapsed/Refractory Cll: Results of Bayesian Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HTA23 Cost-Effectiveness of Antiretroviral Therapy Adherence Interventions in People Living with HIV/AIDS: A Systematic Review of Decision Analytical Models

    Jun 1, 2023, 00:00

  • HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable

    Jun 1, 2023, 00:00

  • RWD15 Epidemiology Description, Treatment Patterns, Resource Utilization and Biomarker Testing of Metastatic Triple Negative Breast Cancer (TNBC) Patients in Costa Rica

    Jun 1, 2023, 00:00

  • PCR179 Patient Preferences in Pulmonary Arterial Hypertension (PAH), a Latent Class Analysis to Identify Preference Heterogeneity

    Jun 1, 2023, 00:00

  • EE101 Use of Patient-Reported Outcomes As Key Drivers in Cost-Effectiveness Models: A Review of UK National Institute for Health and Care Excellence Health Technology Assessments

    Jun 1, 2023, 00:00

  • MSR21 Impact of Correlated Outcomes in Probabilistic Sensitivity Analyses When Treatment Effects Are Derived from a Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HSD36 Economic Burden of Newly Diagnosed Patients with Plantar Fibromatosis (PF) in the United States (US)

    Jun 1, 2023, 00:00

  • HSD12 Measuring Psoriasis Disease Activity in the Real-World Setting: Relationship between the Physician Global Assessment and Body Surface Area Product and the Psoriasis Area and Severity Index

    Jun 1, 2023, 00:00

  • EE567 Economic Impacts of Short-Term Projections of the Judicialization of Medicines on the Expenditure and Budget for Pharmaceutical Assistance in Brazil

    Jun 1, 2023, 00:00

  • EE46 Cost-Effectiveness of Alpelisib Plus Fulvestrant in Postmenopausal Women with Hr+/HER2- Advanced Breast Cancer (ABC) in Oman

    Jun 1, 2023, 00:00

  • MT40 Comparing Resource Consumption from an Economic Evaluation of Gore® Viatorr® Tips Endoprosthesis Versus Large Volume Paracentesis in the Spanish and U.K. Healthcare Systems

    Jun 1, 2023, 00:00

  • SA13 The Effect of Treatment Discontinuation Definitions on Estimates of Treatment Persistence – A Multi-Indication Study with Health Insurance Claims Data

    Jun 1, 2023, 00:00

  • PCR226 Symptoms, Treatment Effectiveness and Quality of Life for Patients Living with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) in the United States: Patient and Caregiver Reported Outcomes from LC-FAOD Odyssey

    Jun 1, 2023, 00:00

  • PCR218 Evaluating the Adherence of Reporting Patient Reported Outcomes to the Consort PRO Extension, CONSORT-Outcomes Extension and ISOQOL Standards Among Aggressive Large B Cell Lymphoma Patients: Systematic Literature Review of RCTs

    Jun 1, 2023, 00:00

  • RWD104 Generalization of the Effectiveness of Baricitinib 4MG Among bDMARD-IR Rheumatoid Arthritis Patients from a RCT to a Real-World Population in China

    Jun 1, 2023, 00:00

  • RWD119 Real-World Evidence on the Association between the Use of Cannabis and Healthcare Resource Utilization Among Patients with Chronic Post-Traumatic Stress Disorder

    Jun 1, 2023, 00:00

  • EE311 Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) Using the Standard of Care in Central America

    Jun 1, 2023, 00:00

  • HPR64 Implications of Inflation Reduction Act (IRA) on Budget Impact and Cost-Effectiveness Modeling

    Jun 1, 2023, 00:00

  • SA5 Defining Colorectal Cancer Recurrence with Structured-Health Data Algorithms: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • RWD114 Is Medicare's Hospital Readmissions Reduction Program (HRRP) Delivering on the Decade's Promise?: A Trend Analysis

    Jun 1, 2023, 00:00

  • PCR90 Pilot Testing a Patient-Driven Discrete Choice Experiment Instrument for Patients with Chronic Obstructive Pulmonary Disease: Methods and Qualitative Results

    Jun 1, 2023, 00:00

  • EE28 Identifying Factors Underlying Variation in the Cost of Acetabular Labral Repair or Debridement during Hip Arthroscopy: A Time-Driven Activity-Based Costing Analysis

    Jun 1, 2023, 00:00

  • SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?

    Jun 1, 2023, 00:00

  • EPH254 Proactive Drug Safety Monitoring of Adverse Drug Events in Saudi Arabia: 2022 Experience

    Jun 1, 2023, 00:00

  • HTA74 HTA Processes for Medical Technologies across the World – Are All Hurdles the Same?

    Jun 1, 2023, 00:00

  • Reviewer Acknowledgment

    Jun 1, 2023, 00:00

  • EE369 Soothing the Soul: Cost-Effectiveness Evaluation of Group Music Therapy in Reducing Clinically-Significant Agitation Among People with Dementia

    Jun 1, 2023, 00:00

  • HTA36 The First Managed Entry Agreements Based on Health Technology Assessment Approved in Ukraine: Analysis and Future Perspectives

    Jun 1, 2023, 00:00

  • EE442 Direct Expenses Study of Liver Transplantation Treatment

    Jun 1, 2023, 00:00

  • RWD58 Real-World Evidence (RWE) Opportunities to Enhance Local Decision-Making in Oncology for Emerging Markets: A Multi-Regional Oncologist Payer Committee Perspective

    Jun 1, 2023, 00:00

  • HPR84 Pre-Approval Information Exchange (PIE). Are US Healthcare Decision Makers and Manufacturers Both Getting a Piece of the Pie?

    Jun 1, 2023, 00:00

  • EE13 Cost and Benefits of Offering Transanal Irrigation Therapy to Medicare Beneficiaries with Spinal Cord Injury Related Neurogenic Bowel Dysfunction Who Failed Standard Bowel Care

    Jun 1, 2023, 00:00

  • OP8 Assessment of the PharmD Pharmacoeconomics Educational Environment in the United States

    Jun 1, 2023, 00:00

  • CO30 Highlighting the Multidimensional Benefits of a Drug Using Generalized Pairwise Comparisons

    Jun 1, 2023, 00:00

  • EE25 A Systematic Literature Review to Assess the Modeling Approaches in Economic Evaluations of Health Interventions for Adult Binge Eating Disorders

    Jun 1, 2023, 00:00

  • HTA87 Caplacizumab for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (ATTP): Technology Qualification in Colombia

    Jun 1, 2023, 00:00

  • MSR20 NLP and Machine Learning to Automate Identification of Suspected Medication Errors from Real World Unstructured Narratives

    Jun 1, 2023, 00:00

  • Impact of Adherence and Intervention on Health Outcomes and Cost

    Jun 1, 2023, 00:00

  • EE450 Assessment of the Quality of Time-Driven Activity-Based Costing (TDABC) Studies on Cardiovascular Diseases and Oncology

    Jun 1, 2023, 00:00

  • HPR21 Implementation Challenges and Real-World Impacts of Switching Pediatric Vaccines: A Global Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?

    Jun 1, 2023, 00:00

  • MSR8 Update on the LIVESTARTTM Artificial Intelligence (AI) Systematic Literature Review (SLR) Tool – Can It Aid in Limited Data Extraction for LIVEREFTM?

    Jun 1, 2023, 00:00

  • EE199 Cost-Effectiveness of Pembrolizumab for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Colombia

    Jun 1, 2023, 00:00

  • EPH81 Medical Attentions Not Directly Related to Patient's Tumor in an Oncologic Center

    Jun 1, 2023, 00:00

  • CO168 Defining Clinically Meaningful Thresholds (CMT) for Forced Vital Capacity (FVC) and Six-Minute Walk Test (6MWT) in Patients with Late-Onset Pompe Disease (LOPD)

    Jun 1, 2023, 00:00

  • EE519 Effect of Surgical Choices on the Cost of Breast Cancer Care

    Jun 1, 2023, 00:00

  • EE524 Validity and Reliability of the EQ-5D-5L and Propr in Patients with Spinal Muscular Atrophy

    Jun 1, 2023, 00:00

  • EE513 Economic Evaluation of Universal Lynch Syndrome Screening Protocols Among Newly Diagnosed Patients with Endometrial Cancer

    Jun 1, 2023, 00:00

  • PCR150 Effects of Smoking on the Prevalence of Self-Reported Antihypertensive Medication Use Among Community-Dwelling Stroke Survivors

    Jun 1, 2023, 00:00

  • HSD73 Characteristics of Type 2 Diabetes Patients That Used Virtual Care Since COVID-19 Pandemic: Evidence from a Large Commercial Healthcare Claims Database in the US

    Jun 1, 2023, 00:00

  • EE112 Budget Impact Analysis of Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low, Intermediate, and High-Risk Patients with Severe, Symptomatic Aortic Stenosis in the United States

    Jun 1, 2023, 00:00

  • EPH236 Hospitalizations Related to Cytopenias Among the Multiple Myeloma Adult Inpatient Population in the United States

    Jun 1, 2023, 00:00

  • EPH194 Exploring the Association of Pain Severity and Perceived Health Status Among United States Adults Using 2019 Nationally Representative Data

    Jun 1, 2023, 00:00

  • EE292 Health Care Resource Utilization and Medical Costs before and after Initiation of Epidiolex in Commercially Insured Patients in the US

    Jun 1, 2023, 00:00

  • PCR85 Sustained Humanistic Burden and Work Impact in Adults with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises: Results from a Global Longitudinal Survey

    Jun 1, 2023, 00:00

  • RWD55 Predicting Metastatic Disease Progression in Prostate Cancer Patients Using Machine Learning of PSA Kinetics

    Jun 1, 2023, 00:00

  • EE270 The Economic Burden of Metastatic Non-Small Cell Lung Cancer in US Patients without an EGFR or ALK Mutation

    Jun 1, 2023, 00:00

  • EE168 Budget Impact Analysis of Adopting Lanreotide in the Treatment of Acromegaly and GEP-NET at Public Hospitals in Saudi Arabia

    Jun 1, 2023, 00:00

  • EE422 Estimated Annual Costs for Hemophilia a Care in Brazil

    Jun 1, 2023, 00:00

  • CO212 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Immune Checkpoint Inhibitors for Treatment of Metastatic NTRKGene Fusion-Positive Cancers

    Jun 1, 2023, 00:00

  • P10 The Public's COVID-19 Fatigue and Mental Health Towards COVID-19 Public Health and Social Measures (PHSMS) and Mental Health in China: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • EE419 Budget Impact Analysis of Faricimab for treating patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Costa Rica

    Jun 1, 2023, 00:00

  • EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction

    Jun 1, 2023, 00:00

  • EE565 Health Economic Evaluations on Dengue Vaccine in Indonesia

    Jun 1, 2023, 00:00

  • EE400 Economic Impact of Clinical Pharmacist Interventions in the Neonatal Intensive Care Unit in Qatar

    Jun 1, 2023, 00:00

  • PCR69 Change in the Rates of Non-Adherence with Migraine Medicines in the United States between 2019 and 2021 Using the Medication Adherence Reasons Scale

    Jun 1, 2023, 00:00

  • RWD76 Using Real World Data to Quantify Risk Factors for Ischemic Stroke in Colombia

    Jun 1, 2023, 00:00

  • CO166 Longitudinal Examination of Metastatic Prostate Cancer Utilizing Linked Health Insurance Claims and Germline Genetic Testing Data

    Jun 1, 2023, 00:00

  • EE508 Cost of Liver Cancer Screening in Patients with Cirrhosis

    Jun 1, 2023, 00:00

  • MSR76 Prediction of High End-of-Life Costs Among Adults with Cancer Using a Machine Learning Approach

    Jun 1, 2023, 00:00

  • HPR111 A Systematic Review of Real-World Evidence (RWE) Supportive of New Drug and Biologic License Application Approvals in Rare Diseases

    Jun 1, 2023, 00:00

  • SA20 The Potential of Real-World Evidence to Complement Basket Trials for Tissue Agnostic Drugs Targeting Neurotrophic Tropomyosin-Related Kinase Gene Fusions

    Jun 1, 2023, 00:00

  • EE150 A Budget Impact Analysis of the Introduction of Mosunetuzumab for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)

    Jun 1, 2023, 00:00

  • Cross-Attribute Level Effects Models for Modeling Modified 5-Level Version of EQ-5D Health State Values: Is Less Still More?

    Jun 1, 2023, 00:00

  • EE516 Health Economic Evaluation of Hepatocellular Carcinoma Screening and Optimized Whole Course Management Strategies in China

    Jun 1, 2023, 00:00

  • EE348 Real-World Analysis of Dental Utilization and Costs Among Type I and Type II Diabetics

    Jun 1, 2023, 00:00

  • EPH170 Diagnoses of Long COVID in the United States: Analysis of a Large Claims Database

    Jun 1, 2023, 00:00

  • RWD109 The Use of Real-World Evidence in FDA Regulatory Submissions: A Review

    Jun 1, 2023, 00:00

  • HSD7 Prescribing Behavior Among Community Oncologists for Generics/Biosimilars While Considering Costs or Financial Toxicity When Treating Cancer

    Jun 1, 2023, 00:00

  • EE527 A Systematic Literature Review of the Economic Burden of Leber Hereditary Optic Neuropathy (LHON)

    Jun 1, 2023, 00:00

  • EPH191 Identifying Geographic Disparities in Access to Psoriasis Care in Medicaid Patients

    Jun 1, 2023, 00:00

  • PCR78 Real-World Pain Symptom Trajectory Among Multiple Myeloma Patients Under Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePRO)

    Jun 1, 2023, 00:00

  • HPR89 Trends in Remote Patient Monitoring Among Medicare Beneficiaries during COVID-19: A Comparative Interrupted Time Series Analysis

    Jun 1, 2023, 00:00

  • EE390 Healthcare Resource Utilization (HCRU) and Costs in Patients with Metastatic Urothelial Cancer (MUC) Who Received First-Line (1L) Treatment: Results from Impact UC II

    Jun 1, 2023, 00:00

  • HPR27 Socioeconomic Inequalities in out of Pocket and Catastrophic Health Expenditures Among the Households in Pakistan

    Jun 1, 2023, 00:00

  • EE27 A Novel Cost Impact Analysis Framework and Model to Evaluate Medications for Opioid Use Disorder within the US Criminal Justice System

    Jun 1, 2023, 00:00

  • Patient and Community Preferences for Decision Making in Health Care

    Jun 1, 2023, 00:00

  • HPR50 Exploring the Contribution of Health Gains and Cost-Offsets to Value-Based Drug Prices in Prior ICER Reviews

    Jun 1, 2023, 00:00

  • PCR54 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures (PROMS): Part II Psychometric Properties

    Jun 1, 2023, 00:00

  • Machine Learning in Outcomes Research

    Jun 1, 2023, 00:00

  • PCR2 The Magnitude of the Association between Insulin Adherence Based on Prescription Fill Rate Measures and Glycemic Control: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • HPR139 Impact of Price Negotiation on the Pricing of Anticancer Drugs in China

    Jun 1, 2023, 00:00

  • EE542 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Guatemala

    Jun 1, 2023, 00:00

  • CO229 Differences in 5-Year Weight Loss By Race and Insurance Payer Type in Patients Who Undergo Bariatric Surgery

    Jun 1, 2023, 00:00

  • HSD34 Screening for Colorectal Cancer in Childhood Cancer Survivors

    Jun 1, 2023, 00:00

  • CO181 Clinical Characteristics of Patients with Sars-Cov-2 Omicron Variant and COVID-19 Vaccination with Clinical Outcome Findings in Shanghai, China: A Single Center, Retrospective, Observational Study

    Jun 1, 2023, 00:00

  • HSD29 Predictors of Neurokinin-Receptor Antagonist (NK1-RA) Overuse Among Women with Breast Cancer

    Jun 1, 2023, 00:00

  • PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis

    Jun 1, 2023, 00:00

  • OP19 Early Detection of High-Risk Pregnancy for Blue and Cross Blue Shield of Louisiana Members

    Jun 1, 2023, 00:00

  • EPH148 Burden of Opioid Use Disorder on Hospitals in the United States

    Jun 1, 2023, 00:00

  • CO121 Using Stated-Preferences Methods to Develop a Summary Metric to Determine Successful Treatment of Children with a Surgical Condition to Compare across Hospitals

    Jun 1, 2023, 00:00

  • CO201 Persistency on Conventional Synthetic DMARDS without Evidence of Rheumatoid Arthritis Control; Identifying Populations That May Benefit from Availability of Lower-Cost TNFi Biosimilars

    Jun 1, 2023, 00:00

  • Dynamic Simulation Modeling Methods for Health Economics

    Jun 1, 2023, 00:00

  • EPH246 Real-World Evaluation of Health Disparities in Treatment Patterns for Systemic Lupus Erythematosus

    Jun 1, 2023, 00:00

  • EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value

    Jun 1, 2023, 00:00

  • EPH43 Potential Association of Remdesivir and Hyperkalemia: A Disproportionality Analysis in USFDA Adverse Event Reporting System Database

    Jun 1, 2023, 00:00

  • PCR32 Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

    Jun 1, 2023, 00:00

  • HSD19 Comparing the Health Care Utilization of Those with Limited English Proficiency and Use of a Language Interpreter to Similar Individuals without Use of a Language Interpreter at Mayo Clinic

    Jun 1, 2023, 00:00

  • EE485 Healthcare Utilization and Costs Decreased Over Time with Nusinersen Treatment in Patients with Spinal Muscular Atrophy

    Jun 1, 2023, 00:00

  • PCR96 Benefits of ePRO Measurements (EPROM) in Clinical Trials and Implications from HTA Perspective

    Jun 1, 2023, 00:00

  • EE327 Unfavorable Outcomes Associated with Genetic Screening of HLA-B*13:01 for the Prevention of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Among HIV-Infected Patients in Thailand: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EE84 Cost-Effectiveness of Pembrolizumab Plus Nab-paclitaxel in Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC) Whose Tumors Expressed Pd-L1 (CPS ≥10) in Colombia

    Jun 1, 2023, 00:00

  • EE281 Trends in Approvals and Price at Market Entry of New Drugs for Breast Cancer in the US (1980-2022)

    Jun 1, 2023, 00:00

  • HPR155 The Impact of the CVS-Aetna Merger on Aetna Enrollees’ Access to Specialty Drugs

    Jun 1, 2023, 00:00

  • EE297 Impact of Breathlessness Severity on Quality of Life, Healthcare Use, Productivity Loss and Economic Cost to the Australian Society

    Jun 1, 2023, 00:00

  • EE105 Impact of Clinical Pharmacist Interventions on Economic Outcomes in Women's Wellness and Research Center in Qatar

    Jun 1, 2023, 00:00

  • EPH215 Yearly Trend of Obesity Prevalence Among Hospitalized Patients in the United States: 2017−2021

    Jun 1, 2023, 00:00

  • EE288 The Healthcare Resource Utilisation Associated with Managing Fragile X Syndrome

    Jun 1, 2023, 00:00

  • PCR74 Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials: Analysis of ClinicalTrials.gov (2013-2022)

    Jun 1, 2023, 00:00

  • HSD61 Patient Characteristics, Treatment Patterns, and Outcomes Among Early Tezepelumab Users: An Early View Claims Data Study

    Jun 1, 2023, 00:00

  • EE135 Cost Comparison of a Smartphone-Based Care Platform Versus Traditional Care in Total Knee Arthroplasty in the US: An Integrated Healthcare Delivery System Perspective

    Jun 1, 2023, 00:00

  • HTA72 Predicting Future ICER Value Assessments: A Neural Network Approach

    Jun 1, 2023, 00:00

  • PCR243 Exploring Health Outcomes By Occupation: Using the National Health and Wellness Survey to Describe Differences in Self-Reported Occupation Profiles

    Jun 1, 2023, 00:00

  • PCR151 Adherence to Direct Oral Anticoagulants and Incidence of Stroke/Acute Coronary Syndrome/Systemic Embolism Among Patients with Atrial Fibrillation Using a Marginal Structural Model

    Jun 1, 2023, 00:00

  • SA59 Literature Review of Statistical Methods Comparisons through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Jun 1, 2023, 00:00

  • HSD115 Comparison of Primary Care Quality Among Rural, Urban, and Online Providers: Evidence from a Pooled Analysis of Standardized Patient Studies in China

    Jun 1, 2023, 00:00

  • EE500 Cost-Effectiveness Analysis of Cemiplimab As Second-Line Therapy for Recurrent Cervical Cancer in Japan

    Jun 1, 2023, 00:00

  • P38 Current Practices and Challenges When Submitting Patient Experience Data for US Regulatory Decision-Making: An Industry Survey

    Jun 1, 2023, 00:00

  • EPH155 Relative Effectiveness of Vaccination and Non-Pharmaceutical Interventions on COVID-19 Infection and Deaths in the US

    Jun 1, 2023, 00:00

  • RWD145 Machine Learning and Artificial Intelligence for Clinical Trial Optimization: A Review of Opportunities to Leverage Real World Data

    Jun 1, 2023, 00:00

  • EE184 Economic Burden of Cystic Fibrosis in the United States: A Systematic Review

    Jun 1, 2023, 00:00

  • MSR60 Merc: An R Package for Correcting Measurement Error Bias Based on Regression Calibration Method

    Jun 1, 2023, 00:00

  • EE346 Opportunity Cost of Not Preventing Heart Failure: Case Study of a Public Hospital in Ecuador

    Jun 1, 2023, 00:00

  • PCR220 Symptom Burden in Late-Stage Breast Cancer Patients Treated with CDK Inhibitors Using the PRO-CTCAE

    Jun 1, 2023, 00:00

  • CO165 Comparison of Non-Robotic Surgery Vs. Robot-Assisted Surgery for Radical Prostatectomy

    Jun 1, 2023, 00:00

  • EE354 Cost Benefit Associated with the Use of SITZMARKS® for the Diagnosis of Constipation in an Adult Population

    Jun 1, 2023, 00:00

  • EE143 Cost-Effectiveness of Ocrelizumab in First-Line Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in Chile

    Jun 1, 2023, 00:00

  • EE65 What Is the Wider Carer and Family Burden in Leber’s Hereditary Optic Neuropathy? a Mixed-Methods Study

    Jun 1, 2023, 00:00

  • EE529 Characterizing Attack-Related Health Utility in Hereditary Angioedema

    Jun 1, 2023, 00:00

  • CO9 A Real-World Examination of HBA1C Reduction and Target Achievement Comparing SGLT2 Inhibitors and GLP1 Receptor Agonists As Second-Line Augmentation to Metformin for Treating Type II Diabetes

    Jun 1, 2023, 00:00

  • EE410 The Insurance Payer Perspective on Management Options for Early Pregnancy Loss in the United States

    Jun 1, 2023, 00:00

  • EE102 Fluctuation in Treatment Initiation: Increasing the Accuracy of Modeling Patient Entry in Budget Impact Analyses

    Jun 1, 2023, 00:00

  • EPH181 An Analysis of Patient Characteristics Associated with Myelosuppression Among Small Cell Lung Cancer (SCLC) Patients Treated in US Community Cancer Care Practices

    Jun 1, 2023, 00:00

  • EE136 Cost-Effectiveness Analysis for Implants of Knee Replacement Surgery in the UK: Discrete-Time Cohort Markov Economic Model

    Jun 1, 2023, 00:00

  • EE371 Trends in the Economic Burden of Rheumatoid Arthritis in the US, 2008-2019

    Jun 1, 2023, 00:00

  • HPR106 Identifying Value Drivers for a Novel Treatment Targeting Core Symptoms of Autism Spectrum Disorder

    Jun 1, 2023, 00:00

  • EPH34 Trends in Prescription Contraceptive Use Among US Commercially Insured Women, 2017 – 2021

    Jun 1, 2023, 00:00

  • HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public

    Jun 1, 2023, 00:00

  • EPH157 Environmental Pollution and Socioeconomic Status in Eastern China

    Jun 1, 2023, 00:00

  • P3 Cost Effectiveness of Newborn Genetic Screening for Long QT Syndrome

    Jun 1, 2023, 00:00

  • HPR57 Evidence Demonstration Framework for Medicare Part B and D Products Subject to Inflation Reduction Act (IRA) Price Regulations

    Jun 1, 2023, 00:00

  • PCR46 Preferences for Attributes of Oral Antipsychotic Treatments: Survey Results of Patients Living with Schizophrenia or Bipolar I Disorder

    Jun 1, 2023, 00:00

  • EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV

    Jun 1, 2023, 00:00

  • EPH33 The Female-to-Male Surgical Sterilization Ratio As Another Indicator of the Gender-Equity Gap

    Jun 1, 2023, 00:00

  • PCR71 Does Disease Impact Go Beyond the Healthcare System? Lessons from Generalized Myasthenia Gravis 360°

    Jun 1, 2023, 00:00

  • EPH3 Comparing Cardiac Safety Profile of Metformin and Sulfonylureas in Colorectal Cancer (CRC) Patients with Type 2 Diabetes Mellitus (T2DM): Surveillance, Epidemiology and End Results (SEER) Medicare Analysis

    Jun 1, 2023, 00:00

  • CO182 Developing Methods to Validate Outcome Measures Captured Via Wearable Activity Trackers

    Jun 1, 2023, 00:00

  • EE298 Cost-Effectiveness of E-Cigarettes for Smoking Cessation Among Medicaid Users

    Jun 1, 2023, 00:00

  • HPR40 Price Analysis of New Nervous System Drugs Marketed in the US (1980-2021)

    Jun 1, 2023, 00:00

  • MT12 Evaluation of Digital Mental Health Therapeutics in the United States: A Systematic Literature Review and Mixed-Methods Framework Synthesis

    Jun 1, 2023, 00:00

  • EE100 Application of Real-World Data in Health Economic Evaluations in China: A Systematic Review

    Jun 1, 2023, 00:00

  • RWD13 Representation of Sex at Birth in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer Patient Registry Data By Cancer Type

    Jun 1, 2023, 00:00

  • EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients

    Jun 1, 2023, 00:00

  • PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members

    Jun 1, 2023, 00:00

  • EE517 The Potential Effect of Future Medical Cost Changes on the Net Cost of Multi-Cancer Early Detection Testing

    Jun 1, 2023, 00:00

  • EPH15 Increased Risk of Adverse Events Following Burn Injury in Patients with Hypothyroidism

    Jun 1, 2023, 00:00

  • EE318 Trends in Prices of New Oral Drugs for Chronic Use Approved By the FDA (1980-2021)

    Jun 1, 2023, 00:00

  • EPH66 Epidemiological Population Study of Sars-Cov-2 in Lake County, Illinois: Contact: Health-Related Quality of Life Assessment

    Jun 1, 2023, 00:00

  • EE109 Cost Effectiveness of Dual Vs. Triple Therapy in Management of Atrial Fibrillation with Percutaneous Coronary Intervention

    Jun 1, 2023, 00:00

  • EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission

    Jun 1, 2023, 00:00

  • HPR100 Trends in FDA Approvals of Cardiovascular Drugs and Medical Devices (1980-2021)

    Jun 1, 2023, 00:00

  • EPH59 Validating Claims-Based Identification of Patients with Overweight and Obesity Using a Linked Claims-Electronic Medical Record Database

    Jun 1, 2023, 00:00

  • EPH31 Incidence of Malignancies in Sickle Cell Disease: A Systematic Review

    Jun 1, 2023, 00:00

  • EE161 An Assessment of the Direct and Indirect Costs of Bladder Cancer Preceding and Following a Cystectomy: A Real-World Evidence Study

    Jun 1, 2023, 00:00

  • An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments

    Jun 1, 2023, 00:00

  • HSD108 Adapting Evidence-Based Peri-Discharge Interventions for Reducing 30-Day Hospital Readmissions Among COPD Patients in Hong Kong: A Delphi Study Guided By the Grade Evidence-to-Decision Framework

    Jun 1, 2023, 00:00

  • RWD3 Group-Based Trajectory Modeling to Evaluate Adherence Patterns for Direct Oral Anticoagulant Among Patients with Atrial Fibrillation

    Jun 1, 2023, 00:00

  • EPH95 Evaluation of Adverse Drug Reactions and Quality of Life of HIV Patients Assessing Care at Public Secondary Hospitals in Ilorin, Nigeria

    Jun 1, 2023, 00:00

  • EE545 Economic Burden in Patients with Hemophilia with Inhibitors: Results from a Real-World Cohort Study in the United States

    Jun 1, 2023, 00:00

  • EE131 Post-Traumatic Stress Disorder (PTSD) in Caregivers: Review of the Existing Evidence and Proposed Framework to Estimate Economic Burden

    Jun 1, 2023, 00:00

  • MSR13 Identification of Longitudinal Trajectories of Medication Non-Adherence and Their Time-Varying Predictors in Aging Patients in the United States

    Jun 1, 2023, 00:00

  • RWD166 Comparative Real-World Retrospective Data Analysis of Comorbid Conditions and Healthcare Utilization for Patients with Myotonic Dystrophy over a 5-Year Timeframe

    Jun 1, 2023, 00:00

  • EE466 Correcting a Cost-Effectiveness Analysis (CEA) with Suggestions on Ways of Avoiding Misinterpretations and Calculating Errors Associated with Them: The Singapore Diabetes Prevention (CEA)

    Jun 1, 2023, 00:00

  • EE193 Burden of Severe Infections in Primary Immunodeficiency (PI) Diseases

    Jun 1, 2023, 00:00

  • HSD91 Practice Patterns and Patient Management Techniques Utilizing Patient-Reported Outcomes Among Community Oncologists

    Jun 1, 2023, 00:00

  • PCR145 A Qualitative Exploratory Study on Developing and Selecting Potential Bolt-on for the EQ-5D Hong Kong Sar, China

    Jun 1, 2023, 00:00

  • HSD26 Relationship between Sociodemographic Factors and Postpartum Depression Screening and Treatment

    Jun 1, 2023, 00:00

  • HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru

    Jun 1, 2023, 00:00

  • EE145 Real-World Healthcare Resource Use, Costs, and Treatment Patterns in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with Different Epidermal Growth Factor Receptor Mutation Types

    Jun 1, 2023, 00:00

  • RWD44 Use of Real-World Data for Hard-to-Identify Patient Population: Methodology and a Case Study

    Jun 1, 2023, 00:00

  • CO138 Comparative Effectiveness and Costs of Sacubitril/Valsartan Versus Angiotensin Receptor Blockers in Heart Failure with Preserved Ejection Fraction

    Jun 1, 2023, 00:00

  • HPR7 Racialized Economic Segregation and Inequities in Survival Among Patients with Multiple Myeloma

    Jun 1, 2023, 00:00

  • EE333 Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S.

    Jun 1, 2023, 00:00

  • EE40 Identifying and Quantifying Elements of Value for Nivolumab and Ipilimumab in First-Line Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • EE337 Per-Member Per-Month Expenditure Value in Non-Oncology: A Targeted Review and Opinion

    Jun 1, 2023, 00:00

  • SA37 Real-World Treatment Patterns (TxP) and Healthcare Resource Utilization (HRU) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) and Metastatic Hormone-SensitiveProstate Cancer (mHSPC) in China

    Jun 1, 2023, 00:00

  • MSR74 Comparison of Cure Versus Standard Parametric Models Using Advanced Melanoma Data

    Jun 1, 2023, 00:00

  • PCR136 A Retrospective Analysis of Real-World Treatment Patterns in Patients over Age 64 with Dry Eye Disease Receiving OTX-101 Ophthalmic Solution 0.09%, Cyclosporine Ophthalmic Emulsion 0.05%, or Lifitegrast Ophthalmic Solution 5%

    Jun 1, 2023, 00:00

  • HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare Advantage Versus Traditional Fee-for-Service

    Jun 1, 2023, 00:00

  • EPH231 Cardiovascular Burden of Patients Diagnosed with Idiopathic Hypersomnia: Real-World Idiopathic Hypersomnia Total Health Model (CV-RHYTHM)

    Jun 1, 2023, 00:00

  • EE319 Healthcare Resource Utilization and Direct Medical Costs Associated with Post COVID-19 Condition in Colombia, 2020-2021

    Jun 1, 2023, 00:00

  • SA45 Dealing with Uncertainty in Cost-Effectiveness and Affordability to Inform Risk-Averse Healthcare Decision Makers

    Jun 1, 2023, 00:00

  • RWD84 A Comparison of Oral Aripiprazole with an Ingestible Sensor with Oral Atypical Antipsychotic Treatment and Impact on Psychiatric Hospitalizations in Adults with Schizophrenia in a Real-World Care Setting

    Jun 1, 2023, 00:00

  • MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS

    Jun 1, 2023, 00:00

  • PCR213 Fear of Progression in Multiple Sclerosis: Evaluation of Existing Patient-Reported Outcomes (PRO) Instruments

    Jun 1, 2023, 00:00

  • PCR185 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study of Tildrakizumab in Patients with Moderate to Severe Plaque Psoriasis

    Jun 1, 2023, 00:00

  • HTA27 A Pipeline Analysis of Immuno-Oncology Medicines - Pembrolizumab, Nivolumab, and Atezolizumab

    Jun 1, 2023, 00:00

  • EE245 Years of Potential Productive Life Lost Mortality Caused By Injury in Mongolia

    Jun 1, 2023, 00:00

  • EPH23 Disease Modifying Therapy (DMT) Utilization and Health Care Resource Utilization (HCRU) Among Adults with Multiple Sclerosis (MS) in a United States-Based Real-World Cohort

    Jun 1, 2023, 00:00

  • EE555 Cost-Effectiveness of Etranacogene Dezaparvovec for the Treatment of Hemophilia B

    Jun 1, 2023, 00:00

  • CO177 The Burden of Spinal Muscular Atrophy Type 1 on Caregivers in Argentina: First Results of a Global Survey Launched in Latin America

    Jun 1, 2023, 00:00

  • CO14 Disparities in COVID-19 Related Outcomes in the United States By Race and Ethnicity: An Umbrella Review of Meta-Analyses

    Jun 1, 2023, 00:00

  • HTA61 Do NICE Technology Appraisals Account for Unmet Medical Need in Oncology?

    Jun 1, 2023, 00:00

  • EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective

    Jun 1, 2023, 00:00

  • P27 The Impact of Incorporating Survival Heterogeneity into Modeling of Survival Outcomes for Patients with Muscle-Invasive Bladder Cancer after Radical Resection: Analyses from a Retrospective Real-World Study in France

    Jun 1, 2023, 00:00

  • CO125 Efficacy of Clascoterone Cream 1% for up to 12 Months in Patients ≥9 Years of Age with Acne vulgaris: Results from a Long-Term Extension Study

    Jun 1, 2023, 00:00

  • PCR138 Multimorbidity and Chronic Pain Management with Opioids and Other Therapies Among Adults in the United States

    Jun 1, 2023, 00:00

  • EE81 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab (NIVO+IPI) Versus Pembrolizumab Plus Axitinib (PEM+AXI) for the First-Line Treatment of Intermediate- and Poor (I/P)-Risk Advanced Renal Cell Carcinoma Patients in Colombia

    Jun 1, 2023, 00:00

  • EPH209 Descriptive Analysis of High-Cost Claimants in a Multi-Employer Database

    Jun 1, 2023, 00:00

  • PCR120 Association of Race/Ethnicity and Patient Care Experiences with Receipt of Definitive Treatment Among Prostate Cancer Survivors: A SEER-CAHPS Study

    Jun 1, 2023, 00:00

  • PCR201 Digital Health Literacy of Parents and Health-Related Quality of Life of Their Children with Type 1 Diabetes Mellitus

    Jun 1, 2023, 00:00

  • PCR125 Development of a Pediatric Version of the Study Medication Withdrawal Questionnaire (SMWQ)

    Jun 1, 2023, 00:00

  • RWD176 Use of the Narcotics Information Management System (NIMS) Data for Regulatory Scien Focusing on Methylphenidate Prescription

    Jun 1, 2023, 00:00

  • PCR99 Regular COVID-19 Booster Shot Preference and Willingness to Pay in the Vietnamese Population: A Theory-Driven Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • SA9 A Comparison of All-Cause and Knee Osteoarthritis (KOA)-Related Costs of Newly-Diagnosed Koa Patients Treated with Multi-Injection IA-HAs: A Retrospective Database Analysis

    Jun 1, 2023, 00:00

  • EE223 Impact of Inclusion of Vericiguat in the Burden of Disease of Heart Failure with Reduced Ejection Fraction (HFREF) and Worsening HF Event in Colombia

    Jun 1, 2023, 00:00

  • RWD171 Disparity in Disease Severity and Treatment Utilization for Atopic Dermatitis (AD) Patients in the US

    Jun 1, 2023, 00:00

  • RWD143 Lift Off: From Real World Data Quality Guidelines to Actionable Assessment

    Jun 1, 2023, 00:00

  • MSR109 When Can an Unanchored Analysis be More Credible Than an Anchored One?

    Jun 1, 2023, 00:00

  • P44 Moral Hazard Effects of Payment Methods Reform in China

    Jun 1, 2023, 00:00

  • CO41 Real-World Outcomes of Nusinersen or Onasemnogene Abeparvovec (OA) Monotherapy, or Switching to OA from Nusinersen in SMA Patients Aged ≥6 Months

    Jun 1, 2023, 00:00

  • EPH69 Economic Impact of Clozapine Treatment Persisten A Canadian Perspective

    Jun 1, 2023, 00:00

  • RWD165 Inequities Related to Life Expectancy of Duchenne Muscular Dystrophy in Brazil: An Administrative Database Analysis

    Jun 1, 2023, 00:00

  • EE63 Cost-Hemophilia Brazil

    Jun 1, 2023, 00:00

  • EE146 Cost-effectiveness of Tepotinib for Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Harboring Metex14 Skipping Alterations in Spain

    Jun 1, 2023, 00:00

  • P42 Value-Based Pricing for Drugs with Accelerated Approval Incorporating Uncertainty and Risk Aversion

    Jun 1, 2023, 00:00

  • HSD79 Trends of Genetic Testing Patterns, Survival, and Medical Costs of Individuals Newly Diagnosed with Metastatic Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments

    Jun 1, 2023, 00:00

  • CO97 Risk Factors, Presentation and Outcome in Acute Ischemic Stroke According to Social Position Indicators in Patients Hospitalized in a Referral Center in Bogotá 2011-2019

    Jun 1, 2023, 00:00

  • EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Jun 1, 2023, 00:00

  • PCR240 Comprehension of the Urticaria Activity Score (UAS) Measure and Patient Guidance Document: Qualitative Interviews with Adults and Adolescents with Chronic Spontaneous Urticaria (CSU)

    Jun 1, 2023, 00:00

  • MSR11 A Multi-Method Approach to an Indirect Treatment Comparison of Eplontersen and Vutrisiran for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    Jun 1, 2023, 00:00

  • EE448 The Burden of Illness for Metastatic Synovial Sarcoma (MSS) and Myxoid Round Cell Liposarcoma (MMRCLS): A Seer-Medicare Analysis

    Jun 1, 2023, 00:00

  • P60 Cost-Related Medical Care Use Reduction and Mediation Nonadherence in US Adults with Multiple Chronic Conditions: A Comparison of High Deductible Health Plans and Traditional Insurance Enrollees

    Jun 1, 2023, 00:00

  • EE214 Unravelling the Elements of Value of Health Care and Assessing Their Importance Using Evidence from Two Discrete-Choice Experiments in England

    Jun 1, 2023, 00:00

  • MT18 Effectiveness, Safety and Economic Evaluation of Using Varied-Height Surgical Staplers in Laparoscopic Hepatectomy for Liver Cancer: A Retrospective, Real-World Study

    Jun 1, 2023, 00:00

  • EPH98 Cutaneous Adverse Drug Reactions of COVID-19 Vaccines: A Cross-Sectional Study of the Largest Healthcare System in Taiwan

    Jun 1, 2023, 00:00

  • HTA41 Surrogate Endpoints in Oncology: A Review of Recent Health Technology Appraisals in the United Kingdom

    Jun 1, 2023, 00:00

  • EPH158 Assessment of the Effectiveness of Primary Health Care By Health Care Managers

    Jun 1, 2023, 00:00

  • HPR117 Cross-Category Competition in Chinese Basic Medical Insurance Drug Formulary

    Jun 1, 2023, 00:00

  • CO69 Patient Journey of Triple Negative Breast Cancer in Five Healthcare Institutions from Colombia

    Jun 1, 2023, 00:00

  • CO203 Cumulative Anticholinergic Burden and Its Predictors Among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors

    Jun 1, 2023, 00:00

  • PCR101 Coverage of Aspects of Occupational Functioning By Health State Utility Instruments

    Jun 1, 2023, 00:00

  • RWD81 Long-Term Metabolic Sequelae of COVID-19, By Severity Levels

    Jun 1, 2023, 00:00

  • HSD63 Real-World Data Analysis of Genetic Testing for Inherited Retinal Diseases

    Jun 1, 2023, 00:00

  • EE96 Budget Impact Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica

    Jun 1, 2023, 00:00

  • CO150 Risk Factors for Therapeutic Failure to Vancomycin in Adults with Methicillin-Resistant Staphylococcus Aureus Infection Treated in a Hospital in Cali, Colombia

    Jun 1, 2023, 00:00

  • HSD6 Unnecessary Staging Imaging in Patients with Early Stage Breast Cancer Varies By Cancer Stage: Are We Choosing Wisely?

    Jun 1, 2023, 00:00

  • PCR63 A Time Trade-Off Study to Estimate Respiratory Syncytial Virus (RSV) Related Utility Values for Older Adults (OA) in the United States (US)

    Jun 1, 2023, 00:00

  • EPH140 Safety of PDE-5 Inhibitors for Erectile Dysfunction: Descriptive and Disproportionality Analyses of the FDA Adverse Event Reporting System (FAERS) Database from 2010 to 2022

    Jun 1, 2023, 00:00

  • EE304 Induction Cost per Responder of Biologic Therapies for Plaque Psoriasis in Canada

    Jun 1, 2023, 00:00

  • PCR79 Unmet Needs in Therapeutic Trajectories of Adult Patients Living with Lung Cancer in Chile: A Qualitative Case Study

    Jun 1, 2023, 00:00

  • CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study

    Jun 1, 2023, 00:00

  • CO154 Are Biosimilars Equivalent to Originator Molecules in the Real-World? Assessments of Efficacy, Toxicity, and Tolerability of Infliximabs in Infliximab-Naïve Patients with Rheumatoid Arthritis

    Jun 1, 2023, 00:00

  • P6 Ethno-Racial Disparity Among Elderly Patients with Alzheimer’S Disease in the US Population: A Real World Study Based on Administrative Claims and Electronic Health Records Data

    Jun 1, 2023, 00:00

  • PCR223 Real-World Observational Study of Mogamulizumab in Adult Patients with Mycosis Fungoides and Sézary Syndrome (PROSPER)

    Jun 1, 2023, 00:00

  • EPH68 Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder in West Virginia

    Jun 1, 2023, 00:00

  • CO40 Impact of Long-Acting Modality on Health Technology Assessments and Formulary Decision Making in the EU4 and USA

    Jun 1, 2023, 00:00

  • EE554 Budget Impact Analysis of Intravenous Acetaminophen in Neonates after Esophageal Atresia and Tracheoesophageal Fistula Repair

    Jun 1, 2023, 00:00

  • RWD131 Treatment Patterns, Healthcare Resource Utilization (HCRU), and Direct Costs for Bacterial Vaginosis (BV) in US Commercially Insured Populations

    Jun 1, 2023, 00:00

  • HSD80 How Are We Treating Our Patients? An Experts’ Panel Perspective from Brazilian Healthcare System on Treatment Access for Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Jun 1, 2023, 00:00

  • RWD155 Lumateperone Persistency for the Treatment of Schizophrenia

    Jun 1, 2023, 00:00

  • EE523 Analysis of Healthcare Resource Utilization and Costs in Patients with Glycogen Storage Disease Type Ia (GSDIA)

    Jun 1, 2023, 00:00

  • HPR95 Inflation Reduction Act: Assessing the Impact for New Drug Development, Launch, Life Cycle Management and Loss of Exclusivity

    Jun 1, 2023, 00:00

  • EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia

    Jun 1, 2023, 00:00

  • CO152 Risk Factors Associated with Long Bone Fracture Non-Union – A US Claims Database Analysis

    Jun 1, 2023, 00:00

  • EE284 Exploring the Value of a Novel Health Technology Tool to Support Diagnosis of Autism Spectrum Disorder

    Jun 1, 2023, 00:00

  • MSR30 Comparison of Search Design and Output of Embase Using Two Different Search Interfaces: Embase.com and OVID

    Jun 1, 2023, 00:00

  • Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

    Jun 1, 2023, 00:00

  • EPH44 On the Frontline Against COVID-19: Provision of Community Pharmacy Services during a Public Health Crises

    Jun 1, 2023, 00:00

  • HSD119 Influence of HEOR Evidence to Challenge the Status Quo for Training General Practitioners: A Case Study from Argentina

    Jun 1, 2023, 00:00

  • Award Winners

    Jun 1, 2023, 00:00

  • EPH116 Epidemiological and Economic Impact of a Rapid Antiretroviral Therapy Initiation in Newly Diagnosed People Living with HIV, from the Colombian’s Health System Perspective

    Jun 1, 2023, 00:00

  • PCR167 Patient Preferences for Lung Cancer Interception Therapy

    Jun 1, 2023, 00:00

  • EE459 Racial Health Disparities in Acute Ischemic Stroke: A Targeted Literature Review for Estimates to be Used in Distributional Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • CO39 Real-World Assessment of Efficacy and Safety of Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • HSD88 A Practical Approach for the Adoption of the Hub and Spoke Model for Cell and Gene Therapies in Low- and Middle-Income Countries: Framework and Simulation Case Studies

    Jun 1, 2023, 00:00

  • EE53 Cost-Minimization and Budget Impact Analysis of Venetoclax Versus Acalabrutinib for 1L and R/R Chronic Lymphocytic Leukemia in the Brazilian Public Healthcare System

    Jun 1, 2023, 00:00

  • PCR28 Characterization of Patients with Duchenne Muscular Dystrophy across Previously Developed Health States

    Jun 1, 2023, 00:00

  • MSR36 How Does the Use of Different Targeted Literature Review (TLR) Methodologies Impact the Research Output? a Case Study of Structured Vs. Focused Vs. Pearl Growing Approach

    Jun 1, 2023, 00:00

  • HSD104 The Utilization of Antineoplastic Agents and Cost Analysis for Chinese Patients with Lung Cancer: A Retrospective Hospital Database Study

    Jun 1, 2023, 00:00

  • HTA71 Transition Probabilities in State-Transition Models: A Synopsis of HTA Guidelines Worldwide

    Jun 1, 2023, 00:00

  • EPH183 Impact of a Cancer Diagnosis on Non-Cancer Chronic Disease Medication Adherence - A Systematic Literature Review

    Jun 1, 2023, 00:00

  • MT15 Adherence to Positive Airway Pressure Therapy in a Cohort of Colombian Patients with Obstructive Sleep Apnea Syndrome

    Jun 1, 2023, 00:00

  • PCR143 Regulatory Recommendations for Patient Experience Data in North America, Europe, and Asia Pacific

    Jun 1, 2023, 00:00

  • PCR222 The Value of No Cancer Signal Detected Results from Multi-Cancer Early Detection Tests–Perspectives of People in the General Population

    Jun 1, 2023, 00:00

  • HSD106 Trends in Second Generation Antipsychotic Prescribing for Adolescents from 2013-2021

    Jun 1, 2023, 00:00

  • PCR216 Insights from Social Media Posts on the Lived Experience of Alzheimer's Disease

    Jun 1, 2023, 00:00

  • EE389 Budget Impact of a Blood-Based Auto-Antibody Test to Up-Classify Risk of Pulmonary Nodules in a US Medicare Payer Setting

    Jun 1, 2023, 00:00

  • EPH176 What Macro-Level Social Determinants Are Associated with Mental Health Outcomes in Disability-Adjusted Life Year (DALY) for the Population Living in the Organisations for Economic Co-Operation and Development (OECD) Nations?

    Jun 1, 2023, 00:00

  • EE462 The Financial Impact of Closing the Diabetes Hemoglobin HBA1C Care Gap at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2023, 00:00

  • HSD23 Comparison of Drug Utilization Outcomes of Direct Oral Anticoagulants in Medicare Patients

    Jun 1, 2023, 00:00

  • PCR126 Including Patient Relevant Endpoints (QUALITY OF LIFE) in Multicomponent Endpoints with Generalized Pairwise Comparisons

    Jun 1, 2023, 00:00

  • EE349 A Systematic Literature Review, Network Meta-Analysis, and Cost-Effectiveness Analysis of Resmetirom for the Treatment of Nonalcoholic Steatohepatitis

    Jun 1, 2023, 00:00

  • PCR207 Paired - Patient Reported Experiences and Perceived Benefit of Treatment with Dolutegravir/Lamivudine: Interim Analysis (N =100)

    Jun 1, 2023, 00:00

  • CO35 Real-World Effectiveness of Intravitreal Ranibizumab and Aflibercept for Eyes with Central Retinal Vein Occlusion: A Multi-Institutional Cohort Study in Taiwan

    Jun 1, 2023, 00:00

  • EPH168 Regional Variation in Patient Characteristics and Treatment Patterns for over 17 Million COVID-19 Patients in the United States

    Jun 1, 2023, 00:00

  • HSD109 Diabetic Retinopathy Patients at Initiation of Anti-Vascular Endothelial Growth Factor Injection

    Jun 1, 2023, 00:00

  • SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HTA28 Evaluation of the Cost-Effectiveness of Laparoscopic Partial Nephrectomy in Comparison with Open Partial Nephrectomy

    Jun 1, 2023, 00:00

  • EE474 Clinical and Economic Burden of Invasive Escherichia coli Disease Among Medicare-Insured Patients

    Jun 1, 2023, 00:00

  • HPR132 Pricing Variations between Early Access Prices and List Prices in Switzerland

    Jun 1, 2023, 00:00

  • EPH127 Understanding the Burden of Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD): Results from a Clinician Expert Survey

    Jun 1, 2023, 00:00

  • EE381 Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer with the Previous Data in Korean Population

    Jun 1, 2023, 00:00

  • EE242 The Economic Impact of Antimicrobial Stewardship Program in the Adults’ General Medicine Setting in Qatar

    Jun 1, 2023, 00:00

  • HTA3 Analysis of Canadian and International Health Technology Assessment Uncertainty for Spinal Muscular Atrophy Therapies

    Jun 1, 2023, 00:00

  • SA73 Use of Novel Qualitative Research Methods for Evidence Generation

    Jun 1, 2023, 00:00

  • HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic

    Jun 1, 2023, 00:00

  • HTA66 Modified Delphi Research to Seek Consensus on dRTA Disease Model, Treatment, and Management

    Jun 1, 2023, 00:00

  • Economic Considerations of Digital Health Technologies

    Jun 1, 2023, 00:00

  • EE350 Cost-Effectiveness of Mirogabalin in Treatment of Diabetic Peripheral Neuropathic Pain in Mainland China

    Jun 1, 2023, 00:00

  • HSD22 Understanding Barriers and Facilitators to Prescribing Sodium-Glucose Trasnporter-2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction

    Jun 1, 2023, 00:00

  • PCR137 Evaluation of Digital Health Solutions from Two Large Dermatology Epidemiological Studies

    Jun 1, 2023, 00:00

  • CO65 Machine Learning-Based Explanation of Racial-Ethnic Disparities in 5-Year Cancer-Specific Survival Among Hormone Receptor-Positive Breast Cancer Patients in the United States

    Jun 1, 2023, 00:00

  • EPH104 Overview of the Healthcare Systems of the Maghreb Countries: Issues and Progress

    Jun 1, 2023, 00:00

  • SA28 Review of Machine Learning Based Disease Diagnosis Modeling

    Jun 1, 2023, 00:00

  • HTA77 Training and Active Social Participation in the Incorporation of Health Technologies in the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • PCR191 A Review of the Influence of Stakeholder Preference Research on the EtR Framework

    Jun 1, 2023, 00:00

  • EE287 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in England

    Jun 1, 2023, 00:00

  • CO139 A Retrospective Study of Sglt-2 Inhibitors Prescription Disparities and Affordability Among Medicare Patients with Diabetes

    Jun 1, 2023, 00:00

  • PCR27 Parents' Preference and Perception for Childhood Obesity Prevention Strategies in China: A Survey-Based Experiment

    Jun 1, 2023, 00:00

  • EE255 Healthcare Costs of Patients with Amyotrophic Lateral Sclerosis with Commercial or Medicare Insurance

    Jun 1, 2023, 00:00

  • PCR184 Impact of COVID-19 Symptoms on Patients' Health-Related Quality of Life

    Jun 1, 2023, 00:00

  • HTA88 A Systematic Literature Review of the Value of Prophylactic Treatment in Adult Patients with Hemophilia A

    Jun 1, 2023, 00:00

  • EPH61 Uptake of the Post COVID-19 Condition ICD-10-CM Diagnosis Code By Social Factors

    Jun 1, 2023, 00:00

  • HSD65 From the Triple Aim to the Quintuple Aim to the ISPOR Value Flower: Are Health Systems Prepared for High-Value Cell and Gene Therapies?

    Jun 1, 2023, 00:00

  • EE492 Costs of Illness Associated with Relapses in Neuromyelitis Optica Spectrum Disorder: An Administrative Claims Database Analysis

    Jun 1, 2023, 00:00

  • EE67 The Financial Impact of a Newly Introduced Thermosetting, Bioadhesive, Antibacterial Hydrogel to U.S. Commercial and Medicaid Insurers in Treating Bacterial Vaginosis

    Jun 1, 2023, 00:00

  • RWD159 Evolution of Cancer Treatment Cost in the Last 36 Months: An Analysis from a Health Payer Perspective in Brazil

    Jun 1, 2023, 00:00

  • HSD101 The Key Role of Therapeutic Professionals in Rett Syndrome Care Pathway

    Jun 1, 2023, 00:00

  • EE38 Budget Impact of a Blood-Based Integrated Classifier Test to Down Classify Risk of Pulmonary Nodules in a US Medicare Payer Setting

    Jun 1, 2023, 00:00

  • EE300 Clinical and Economic Burden of Exacerbations in Patients with Severe Asthma in South Korea

    Jun 1, 2023, 00:00

  • EPH219 Digital Contact Tracing for COVID-19: Overview of Existing Systems and Framework for Future Innovation

    Jun 1, 2023, 00:00

  • RWD46 Reclassification of COVID-19 Related ICD-10 Codes in Mexico: A Real-World Data Analysis of 1,937,360 Hospital Discharges from the Ministry of Health

    Jun 1, 2023, 00:00

  • EPH27 Association between Prescribing Specialty and Treatment-Related Complications in Patients Using Novel Hormonal Agents for Metastatic Castration-Resistant Prostate Cancer: Population-Based Study

    Jun 1, 2023, 00:00

  • EPH84 Administrative Claims-Based Algorithm to Identify Patients with Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • PCR61 Persistent Work Limitations in Long COVID: A Cross-Sectional Analysis of Employed US Respondents to the 2022 National Health and Wellness Survey

    Jun 1, 2023, 00:00

  • RWD33 Cardiac Implantable Electronic Device Centers’ Landscape in the Brazilian Public Healthcare: A 12-Year Real World Data Analysis

    Jun 1, 2023, 00:00

  • PCR178 Economic and Humanistic Burden of Neurofibromatosis Type 1 in China

    Jun 1, 2023, 00:00

  • CO70 Matching Adjusted Indirect Comparison (MAIC) of Single Tremelimumab Regular Interval Durvalumab (STRIDE) Versus Atezolizumab with Bevacizumab (A+B) for the Treatment of Unresectable Hepatocellular Carcinoma (UHCC)

    Jun 1, 2023, 00:00

  • OP14 Just What the Doctor Ordered? A Review of Clinician Exposure to Health Economics and Outcomes Research

    Jun 1, 2023, 00:00

  • HSD21 Telehealth: Interconnected Future of Healthcare in Emirate of Dubai, a Claims Data Analysis

    Jun 1, 2023, 00:00

  • HSD76 Investigating the Impact of Self-Help Groups on Opioid Use Disorder Treatment Retention

    Jun 1, 2023, 00:00

  • MT46 Real World Use of Circulating Tumor DNA (CTDNA) in Colorectal Cancer (CRC): A Targeted Literature Review (TLR)

    Jun 1, 2023, 00:00

  • HSD25 Study of Pharmacists' Awareness Regarding Coronavirus Disease (COVID-19) in Ukraine

    Jun 1, 2023, 00:00

  • CO225 An Evaluation of the Design of Clinical Trials Conducted for Rheumatoid Arthritis, 2009-2022

    Jun 1, 2023, 00:00

  • EE435 Value for Money of Post-Market Surveillance of Medicines: Evidence from Indonesia

    Jun 1, 2023, 00:00

  • HPR105 Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinsons Disease

    Jun 1, 2023, 00:00

  • PCR208 Patient Preferences for Long-Acting Antiretroviral Therapy Among Patients Living with HIV in Kenya: Results from a Pilot Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • PCR94 Uncovering Patient-Reported Outcome Differences between Undiagnosed and Diagnosed Individuals with Moderate to Severe Psoriasis

    Jun 1, 2023, 00:00

  • EE273 Cost-Effectiveness Analysis of First Line Treatment Strategies for Acute Promyelocytic Leukemia in Adults in Colombia

    Jun 1, 2023, 00:00

  • EE68 Cost-Effectiveness of Using a Novel Machine Learning Algorithm to Diagnose Idiopathic Pulmonary Fibrosis

    Jun 1, 2023, 00:00

  • CO77 Relationships between Heterotopic Ossification Volume and Functional and Quality of Life Endpoints in Fibrodysplasia Ossificans Progressiva (FOP)

    Jun 1, 2023, 00:00

  • HPR128 Use of Clinical Outcomes Assessments (COAS) By Hospitals in the USA, UK, France and Sweden: Multi-Stakeholder Viewpoints

    Jun 1, 2023, 00:00

  • HPR44 Evolving PICO Characteristics in the Early Oncology Treatment Lifecycle: Differences from Trials to Treatment Guidelines

    Jun 1, 2023, 00:00

  • PCR172 Communicating Challenging Concepts in Preference Research: Developing and Testing a Discrete Choice Experiment (DCE) Survey in Metastatic Castration-Resistant Prostate Cancer (MCRPC)

    Jun 1, 2023, 00:00

  • PCR209 Comparing the Value of Daily Measurement of Wellbeing for Individuals with Alcohol Use Disorder Versus Reimbursement-Based Timing

    Jun 1, 2023, 00:00

  • CO64 Efficacy and Safety of Exenatide for the Treatment of Parkinson’s Disease: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EPH46 The Association between Vaccine Hesitancy and Pertussis: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EPH90 Incidence Rate of Infections and Association between Lupus Nephritis and Serious Infections in Patients with Systemic Lupus Erythematosus: Systematic Literature Review and Meta-Analyses

    Jun 1, 2023, 00:00

  • EE226 Cost-Effectiveness Analysis of Fixed-Dose Triple Combination Therapy (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) Vs. Its Fixed-Dose Double Combination and Individual Components

    Jun 1, 2023, 00:00

  • EE440 Trends in the Cost of Total Knee Arthroplasty — a US Hospital Database Analysis, 2000–2021

    Jun 1, 2023, 00:00

  • RWD39 Who Is Using Data from the French Health Data Hub?

    Jun 1, 2023, 00:00

  • CO20 Predictors of Sustainability of Response with Cenobamate: Post-Hoc Subset Analysis of a Phase 3, Open-Label Study

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30 (current)
  • »